Longer follow up of LS-11 showed lenvatinib/belzutifan vs cabozantinib did not reach significant OS HR 0.85 (0.70-1.03). #ESMO26 Other endpoints of RR (54%) and DFS (HR 0.75) remain positive and impressive. TRAEs are 73% vs 66%. This is the most robust 2nd line strategy IMO, as many patients don’t make it to 3rd line. Nevertheless the lack of OS means other sequencing strategies seem reasonable. @DrDanielHeng@OncoAlert
LOAN UPDATE: Mikey Moore has already made his mark in the Bundesliga.
On loan at 1. FC Köln for the rest of the 2026/27 campaign, our young winger made a bright start to life in Germany with a dazzling substitute appearance.
Introduced at the start of the second half as Köln trailed 1-0 away at VfB Stuttgart, Mikey was electric at the MHP Arena and at the heart of every attack from Die Geißböcke.
In the end, it was a bruising evening for Mikey's new side, with them eventually falling to a 4-1 defeat but that was not before our Academy graduate bagged an assist for Köln's only goal.
Linking up with former Manchester City forward Reigan Heskey down the left, the winger reached the byline before hooking the ball back and across the line, it was met by defender Ramon Hendriks, but he could only send it past his own goalkeeper.
Köln currently sit 11th in the Bundesliga with two games played.
#COYS#THFC
HEART UK is proud to have been a partner in this innovative project to increase cholesterol checks through community pharmacies.
It’s just been announced at the European Society of Cardiology congress that the project will be rolled out to a further 100 NHS pharmacies this autumn.
HEART UK looks forward to the next stage of this exciting public health opportunity.
theguardian.com/society/2026…
A special moment yesterday at the ESC Membership 10-year anniversary, receiving an ESC Membership Engagement Award.
A privilege to have contributed to ESC Membership over the past decade, including serving on the Membership Committee.
#ESCCongress2026#ESC#Cardiology
In Nicosia today, President Nikos @Christodulides and Turkish Cypriot Leader Tufan Erhurman met and agreed to hold weekly meetings, or more if required
Today's meeting was the first between the leaders since @UN Secretary-General @antonioguterres visited Cyprus in July 🇺🇳🇨🇾
February Biotech PDUFA Pulse:
📡 What’s on the FDA Radar
Feb 8 | $RGNX – RGX-121 (MPS II / Hunter syndrome), Priority Review
Feb 20 | $MRK – Keytruda® (platinum-resistant recurrent ovarian cancer), Priority Review (label expansion)
Feb 21 | $VNDA – Bysanti™ (bipolar I disorder / schizophrenia)
Feb 25 | $ETON – ET-600 (central diabetes insipidus)
Feb 28 | $ASND – TransCon® CNP (achondroplasia), Priority Review
Feb 28 | $BMRN – PALYNZIQ® (PKU, adolescents), Priority Review (label expansion)
See the attached graphic for the full February PDUFA calendar.
Delighted to see our @escardio Task Force on Allied Professionals paper published.
"A multidisciplinary approach to reduce the burden of cardiovascular disease.."
academic.oup.com/eurjcn/adva…